Scarica l'app Stockscreener
24.79
3.08%
0.74
Dopo l'orario di chiusura:
25.13
0.34
+1.37%
Precedente Chiudi:
$24.05
Aprire:
$25.03
Volume 24 ore:
99,376
Relative Volume:
0.62
Capitalizzazione di mercato:
$53.36M
Reddito:
-
Utile/perdita netta:
$-563.30K
Rapporto P/E:
-124.20
EPS:
-0.1996
Flusso di cassa netto:
$-22.23M
1 W Prestazione:
+18.84%
1M Prestazione:
+89.24%
6M Prestazione:
+130.60%
1 anno Prestazione:
+27.46%
Intervallo 1D:
$24.00
$27.40
Intervallo di 1 settimana:
$20.27
$27.40
Portata 52W:
$6.27
$39.75
Promis Neurosciences Inc Stock (PMN) Company Profile
Nome
Promis Neurosciences Inc
Settore
Industria
Telefono
416-847-6898
Indirizzo
SUITE 200, 1920 YONGE STREET, TORONTO
Compare PMN vs VRTX, REGN, ARGX, ALNY, ONC
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PMN
Promis Neurosciences Inc
|
24.79 | 51.77M | 0 | -563.30K | -22.23M | -0.1996 |
|
VRTX
Vertex Pharmaceuticals Inc
|
460.82 | 121.40B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
764.93 | 83.25B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
728.11 | 46.39B | 4.16B | 1.29B | 734.26M | 19.59 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
320.51 | 43.41B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
292.94 | 33.09B | 5.36B | 287.73M | 924.18M | 2.5229 |
Promis Neurosciences Inc Borsa (PMN) Ultime notizie
Eugene Williams Increases Stake in ProMIS Neurosciences Inc - GuruFocus
Promis Neurosciences (NASDAQ:PMN) Director Eugene Williams Buys 2,000 Shares - MarketBeat
Eugene Williams Acquires 1,000 Shares of Promis Neurosciences (NASDAQ:PMN) Stock - MarketBeat
ProMIS Neurosciences, Inc. (PMN.TO) Competitors - Meyka
PMN Stock Price and Chart — NASDAQ:PMN - TradingView
ProMIS Neurosciences : PMN - 24/7 Wall St.
Ally Bridge entities disclose ProMIS (PMN) shares and warrant terms - Stock Titan
PMN PE Ratio & Valuation, Is PMN Overvalued - Intellectia AI
Can ADMA Biologics Inc deliver consistent EPS growthJuly 2025 Breakouts & Short-Term Trading Alerts - baoquankhu1.vn
Insider Buying: Johanne Kaplan Acquires Shares of ProMIS Neurosc - GuruFocus
Insider buy: ProMIS Neurosciences (PMN) CDO acquires 1,629 shares at $15.35 - Stock Titan
Portfolio Shifts: Can ProMIS Neurosciences Inc. continue delivering strong returnsEarnings Beat & Capital Protection Trading Alerts - baoquankhu1.vn
Final Results - ADVFN
What to expect from Gossamer Bio’s late-stage lung disease study - statnews.com
ProMIS Neurosciences CEO touts “watershed year” as PMN310 Alzheimer’s Phase 1b data nears - Defense World
Is ProMIS Neurosciences Inc. stock positioned well for digital economyWeekly Trend Recap & Smart Swing Trading Techniques - mfd.ru
Promis Neurosciences (NASDAQ:PMN) Cut to “Strong Sell” at Wall Street Zen - Defense World
PMN Should I Buy - Intellectia AI
SPHERA FUNDS MANAGEMENT LTD. Acquires Additional Shares in ProMIS Neurosciences Inc. - GuruFocus
ProMIS Neurosciences: Phase 1b Alzheimer's trial fully enrolled and financed, with pivotal data expected in 2026 - TradingView
Is ProMIS Neurosciences Inc. (23J0) stock a safe buy pre earningsJobs Report & Weekly Breakout Stock Alerts - mfd.ru
Downgrade Watch: Is OPENLANE Inc. on track to beat earningsWeekly Profit Analysis & Verified Technical Signals - baoquankhu1.vn
Guggenheim Remains a Buy on ProMIS Neurosciences (PMN) - The Globe and Mail
Insider Stock Purchases: February 06, 2026 - Quiver Quantitative
ProMIS Neurosciences (PMN) Rating Maintained but Price Target Sl - GuruFocus
ProMIS Neurosciences to Participate in the Guggenheim Emerging Outlook: Biotech Summit 2026 - The Manila Times
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Profit Review: Can ProMIS Neurosciences Inc. continue delivering strong returnsJuly 2025 Trade Ideas & AI Forecasted Entry/Exit Points - baoquankhu1.vn
Promis Neurosciences (NASDAQ:PMN) Short Interest Down 14.8% in January - Defense World
ProMIS Neurosciences, Inc. announced that it expects to receive $75.464029 million in funding from a group of investors - marketscreener.com
ProMIS Neurosciences Announces $75 Million PIPE Financing - The Globe and Mail
ProMIS Neurosciences raises $175 million in PIPE financing By Investing.com - Investing.com South Africa
ProMIS Neurosciences Inc. (PMN) stock: surges 34% after $175M PIPE financing deal - parameter.io
ProMIS Neurosciences Secures $175 Mln In Private Financing - Nasdaq
ProMIS Neurosciences Stock Fluctuates Amid Market Developments - timothysykes.com
ProMIS Neurosciences Signs Multiple Material Agreements - TradingView
ProMIS Neurosciences raises $175 million in PIPE financing - Investing.com
ProMIS Neurosciences stock soars after $175 million private placement By Investing.com - Investing.com South Africa
ProMIS Neurosciences Secures $175 Million in PIPE Financing to Extend Cash Runway and Support Alzheimer’s Disease Clinical Study - Quiver Quantitative
ProMIS Neurosciences stock soars after $175 million private placement - Investing.com
ProMIS Neurosciences Announces Up to $175 Million Private Placement Financing - The Manila Times
ProMIS lines up up to $175M to extend runway into 2028, fund Alzheimer’s trial - stocktitan.net
RSI Check: What hedge funds are buying Akoya Biosciences IncQuarterly Trade Summary & Free Reliable Trade Execution Plans - baoquankhu1.vn
Aug Breakouts: Whats next for ProMIS Neurosciences Inc stockEarnings Beat & Scalable Portfolio Growth Ideas - baoquankhu1.vn
How cyclical is ProMIS Neurosciences Inc.’s revenue streamMarket Activity Recap & Daily Profit Maximizing Trade Tips - bollywoodhelpline.com
Promis Neurosciences (NASDAQ:PMN) Receives Average Rating of “Moderate Buy” from Brokerages - Defense World
Quarterly Earnings: Is ProMIS Neurosciences Inc benefiting from innovation trends2025 Historical Comparison & Expert Curated Trade Setups - baoquankhu1.vn
Aug Breakouts: Can ProMIS Neurosciences Inc continue delivering strong returnsBond Market & AI Optimized Trade Strategies - baoquankhu1.vn
Promis Neurosciences Inc Azioni (PMN) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.69%
0.68%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):